|
|
Volumn 36, Issue 4, 2002, Pages 477-479
|
|
Developments in treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CENTRAL STIMULANT AGENT;
DEXAMPHETAMINE;
METHYLPHENIDATE;
PSYCHOTROPIC AGENT;
ARTICLE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
CHILD;
CHILD PSYCHIATRY;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
ENVIRONMENTAL FACTOR;
HEREDITY;
HUMAN;
PSYCHOSOCIAL CARE;
PSYCHOTHERAPY;
TASK PERFORMANCE;
ADOLESCENT;
CLINICAL TRIAL;
COMORBIDITY;
DIFFERENTIAL DIAGNOSIS;
MULTIMODALITY CANCER THERAPY;
PRESCHOOL CHILD;
PSYCHOLOGICAL ASPECT;
ADOLESCENT;
ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
COMORBIDITY;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
|
|
EID: 0036692488
PISSN: 00048674
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1614.2002.t01-1-01065.x Document Type: Article |
|
Times cited : (2)
|
|
References (14)
|
